Author: centurium

January 25, 2020, Beijing – Centurium Capital today donated RMB2 million to Hubei Charity Federation’s special fund to help hospitals and local authorities fight the recent novel coronavirus pneumonia outbreak, which originated from Wuhan, Hubei’s provincial city and most severely hit.

At the time of Centurium Capital’s donation this morning, China has confirmed 1,287 cases and 41 deaths, as the contagious illness continues to spread across the country, so far affecting 30 provincial-level regions.

January 18, 2020, Beijing – Yunxuetang (“YXT”, or “the Company”), a leading corporate training SaaS and services provider in China, announced today that the company has completed Series D financing round of US$100 million led by Centurium Capital (“the firm”, or “Centurium”), and participated by existing investors YF Capital and SIG. The company has previously raised six rounds of financing totaling US$200 million. According to Ruize Lu, Founder of Yunxuetang, the capital will be used to invest in content development and professional services capabilities enhancement.

Founded in 2011, Yunxuetang provides one-stop training solutions including SaaS, content development and services to thousands of big corporate clients and nearly 30,000 SMEs. Headquartered in Beijing and Suzhou, the company has branch offices in over 20 Chinese cities including Shenzhen and Hangzhou.

Yunxuetang’s total solutions include training infrastructure establishment, training materials development, training program maintenance, data analysis and vendor management to meet increasing demands for more efficient staff training as Chinese companies grow and evolve.

Gary Liu, Executive Director of Centurium Capital, commented, “We are confident of the long-term growth prospects of the business services sector. Yunxuetang’s business model of integrating SaaS, content and services significantly increased the efficiency and quality of staff training efforts of its clients. The core team of Yunxuetang are well respected industry veterans with many years of experience in technology, content development and business services.”

The market size of the corporate training industry reached RMB294 billion in 2018, according to a report by Training magazine. While substantial in size, the industry remains fragmented and without clear market leaders; providing ample opportunities for consolidation.

Ruize Lu, Founder of Yunxuetang, commented, “Other than online training, it has been an emerging trend for training service providers to be able to generate and intelligently match training materials for staff at different levels and positions. Leveraging its resources and innovative SaaS platform, Yunxuetang is developing high-quality training materials and products to meet client demands.”

Centurium’s investment philosophy is to identify investment opportunities in China’s rapidly expanding consumer, services, and healthcare sectors, with an investment strategy centered around the need to “Invest to Transform”. Moreover, the Firm brings a hands-on and operations-centric approach to improve operational efficiency and solve structural deficiencies. Investments made by the Firm include, among other, Luckin Coffee (NASDAQ: LK), China Biologic Products (NASDAQ: CBPO), LOHO and UIB.

近期，我司发现有人非法通过手机移动App客户端假冒大钲资本/Centurium Capital，并通过该假冒大钲资本App发布虚假信息，以销售理财产品为名骗取他人财物，不仅严重侵犯了大钲资本的合法权益，也严重损害了其他公民的利益。

为切实维护广大投资者及我司合法权益，大钲资本特此声明如下：

第一、大钲资本从未通过互联网、移动APP、微信或任何社交媒体等渠道向不特定公众进行资本募集、销售理财产品等商业活动，也从未授权任何个人或实体通过上述公开渠道以我司的名义向公众进行任何此类销售活动。

第二、大钲资本的官方网站为：www.centurium.com，官方微信公众号为：CenturiumCapital。除此以外，大钲资本没有任何其他官网、微信公众号或移动App。如遭遇任何假冒大钲资本的非法行为，请立刻向公安机关、工商管理部门等监管部门报案。

第三、我司将采取一切必要的行动维护我司权益，品牌及声誉，并通过法律手段严厉追究相关个人或实体的法律责任。

在此，我司特别提醒投资者和长期关注我司的各界人士提高防范意识，仔细甄别，不要轻信误导、不实的宣传，通过正规渠道进行投资，以免上当受骗。

特此声明。

大钲资本

2019年11月20日

Hong Kong, November 11, 2019 –– Centurium Capital secured “Firm of the Year – Mid Cap” prize which was announced and presented at the 2019 AVCJ Private Equity & Venture Capital Awards dinner in Hong Kong.

As the industry’s premier information source, the Asian Venture Capital Journal tasks itself with highlighting the firms, professionals, investments, exits and fundraises that are a cut above the rest.

The AVCJ awards have become a mark of distinction in Asian private equity, and a showcase for first-class innovation, ingenuity and performance. They are also unique in the region in how they are distributed – relying primarily on nominations and votes cast by Asia’s entire private equity and venture capital community, but with contributions from a select panel of industry judges as well as the AVCJ Editorial Board. To be selected as a winner is to be truly acknowledged as preeminent.

AVCJ highlighted Centurium Capital’s strategy, fundraising and investment activities in 2019 at the Awards ceremony: “When Centurium Capital closed its debut US dollar fund at $2 billion in July 2019, it had already deployed 40% of the corpus across five deals and secured one liquidity event. The GP raised twice the targeted amount of an investment strategy rooted in the technology-enabled transformation. Early evidence of this came in the form of Luckin Coffee, which leverages technology to deliver supply chain efficiencies and customer insights. Centurium led the company’s series A and B rounds and was the largest external investor when it listed in May. Other investments included LOHO and China Biologic Products.”

Centurium Capital is a leading private equity investment firm in China and manages multiple RMB and US dollar funds, with a primary focus on China’s consumer, service and healthcare sectors. With best-in-class domain knowledge and sector resources, Centurium Capital is committed to disciplined approach and significant equity commitment to ensure deep engagement with invested companies and create long term shareholder value.

September 20, 2019 – Illuvator CoreX, China’s leading artificial intelligence chipmaker and solution provider, announced today that it has completed B-round financing led by Centurium Capital and Princeville Capital, and participated by Shanghai Electric Hong Kong and Bangsheng Capital. The funding will be used to enhance the company’s R&D efforts, market expansion, customer development and mass production.

Founded in 2015 by experts returned from Silicon Valley, Illuvator CoreX develops enterprise AI software and hardware products, platform and cloud-based AI solutions. The company has R&D centers in Shanghai, Beijing, Silicon Valley and Nanjing, led by Founder and CEO Li Yunpeng, who was the technology director of Oracle’s core database department. During his tenure at Oracle, he made important contributions to the successful launch of over 10 versions of Exadata.

Illuvator CoreX targets the AI-enabled high-performance data processing market and features proprietary high-end/cloud-based universal chips and applications, aiming to solve the core capacity issues in today’s AI era.

Industry estimates predict global AI chips market will reach US$ 34.3 billion in 2023 including over US$8.3 billion from China. Li Yunpeng, founder and CEO of Illuvator CoreX, commented that the industry is facing a turning point for increasing demand, and the company will continue to focus on integrated software and hardware approach to deliver full package of solutions that cover all scenarios of calculation capacity.

Beijing, China, July 17, 2019 –– Centurium Capital, a leading private equity firm in China, today announced that Michael Chen had joined the firm as Managing Director. In this new role, Mr. Chen will work closely with Mr. David Li, Chairman and CEO of Centurium Capital, in managing investment activities of the firm.

Mr. Chen has a proven track record as an experienced and successful private equity investor. Before joining Centurium, Mr. Chen was a Managing Director of Warburg Pincus leading its consumer investments in China. During his tenure at Warburg Pincus since 2011, he led a number of investments into leading Chinese companies in transportation and mobility, retail, logistics and education industries.

Mr. Chen commented, “China has come into a new era of real economy and capital market , with both opportunies and challenges. Chinese home-grown private equity firms are well equipped to provide tailor-made solutions for Chinese companies in this new era. With an experienced team, as well as deep sector insights and operational capabilities, Centurium Capital is well postioned to ride this wave and create value for both our portfolio companies and our investors. I’m very excited to join the team and look forward to helping build Centurium into one of the top private equity firms in China.”

Mr. David Li, Chairman and CEO of Centurium Capital, commented, “Michael brings a wealth of expertise and resources through his many years of experience in investment. As the macro trends of consumption upgrade, industry consolidation and technology-driven business innovation continue, Centurium is committed to investing into transformational opportunities to drive portfolio growth. With Michael on board, our investment team is further enhanced, and he will bring tremendous value in our efforts in investment, fundraising and operational suppport to our portfolio companies.”

Prior to joining Warburg Pincus, Mr. Chen was a vice president at Crescent Point, a Pan-Asia growth capital fund. Before Crescent Point, Mr. Chen worked in the investment banking division of Morgan Stanley in Hong Kong and Accenture in China. He received a B.A. of Economics from Fudan University and an M.B.A. from INSEAD.

Centurium Capital is a leading private equity firm in China. With deep domain knowledge and sector resources, Centurium Capital primarily focuses on investing into the China consumer and healthcare sectors. Since its inception, Centurium Capital has received strong support from world-wide leading institutional investors including pension funds, sovereign wealth funds, family offices, corporates and FOFs. The firm seeks to invest in control or significant minority private equity stakes with a particular focus on in-depth engagement to improve operational efficiency and solve structural deficiencies.